Friday, December 8, 2006

NeoVista Scores $41M

Fremont-based NeoVista, a medical devices firm focused on opthalmic devices for treating wet Age-Related Macular Degeneration (AMD), said Thursday that it has closed a third round of venture funding worth $41M. The invesetment was led by new investor Essex Woodlands Health Ventures and MPM Capital. Existing investors Versant Ventures, SV Life Sciences, The Carlyle Group, and Accuitive Medical Ventures also were in this round, which the firm said was over-subscribed. More information »